Revuz JE - Search Results

1

Clinical characteristics of a series of 302 French patients with hidradenitis suppurativa, with an analysis of factors associated with disease severity.

Canoui-Poitrine F, Revuz JE, Wolkenstein P, Viallette C, Gabison G, Pouget F, Poli F, Faye O, Bastuji-Garin S. Canoui-Poitrine F, et al. Among authors: revuz je. J Am Acad Dermatol. 2009 Jul;61(1):51-7. doi: 10.1016/j.jaad.2009.02.013. Epub 2009 Apr 29. J Am Acad Dermatol. 2009. PMID: 19406505

2

Combination therapy with clindamycin and rifampicin for hidradenitis suppurativa: a series of 116 consecutive patients.

Gener G, Canoui-Poitrine F, Revuz JE, Faye O, Poli F, Gabison G, Pouget F, Viallette C, Wolkenstein P, Bastuji-Garin S. Gener G, et al. Among authors: revuz je. Dermatology. 2009;219(2):148-54. doi: 10.1159/000228334. Epub 2009 Jul 8. Dermatology. 2009. PMID: 19590173 Free article.

3

Prevalence and factors associated with hidradenitis suppurativa: results from two case-control studies.

Revuz JE, Canoui-Poitrine F, Wolkenstein P, Viallette C, Gabison G, Pouget F, Poli F, Faye O, Roujeau JC, Bonnelye G, Grob JJ, Bastuji-Garin S. Revuz JE, et al. J Am Acad Dermatol. 2008 Oct;59(4):596-601. doi: 10.1016/j.jaad.2008.06.020. J Am Acad Dermatol. 2008. PMID: 18674845

4

Prognostic value of histologic features of toxic epidermal necrolysis.

Valeyrie-Allanore L, Bastuji-Garin S, Guégan S, Ortonne N, Bagot M, Roujeau JC, Revuz JE, Wechsler J, Wolkenstein P. Valeyrie-Allanore L, et al. Among authors: revuz je. J Am Acad Dermatol. 2013 Feb;68(2):e29-35. doi: 10.1016/j.jaad.2011.10.007. Epub 2011 Nov 16. J Am Acad Dermatol. 2013. PMID: 22088428

5

Identification of three hidradenitis suppurativa phenotypes: latent class analysis of a cross-sectional study.

Canoui-Poitrine F, Le Thuaut A, Revuz JE, Viallette C, Gabison G, Poli F, Pouget F, Wolkenstein P, Bastuji-Garin S. Canoui-Poitrine F, et al. Among authors: revuz je. J Invest Dermatol. 2013 Jun;133(6):1506-11. doi: 10.1038/jid.2012.472. Epub 2012 Dec 13. J Invest Dermatol. 2013. PMID: 23235532 Free article.

6

Quality of life impairment in hidradenitis suppurativa: a study of 61 cases.

Wolkenstein P, Loundou A, Barrau K, Auquier P, Revuz J; Quality of Life Group of the French Society of Dermatology. Wolkenstein P, et al. J Am Acad Dermatol. 2007 Apr;56(4):621-3. doi: 10.1016/j.jaad.2006.08.061. Epub 2006 Oct 20. J Am Acad Dermatol. 2007. PMID: 17097366

7

Back and face involvement in hidradenitis suppurativa.

Poli F, Wolkenstein P, Revuz J. Poli F, et al. Dermatology. 2010;221(2):137-41. doi: 10.1159/000315508. Epub 2010 Jul 5. Dermatology. 2010. PMID: 20606396

8

[Lymphedema as a complication of hidradenitis suppurativa in three patients].

Faye O, Petit F, Poli F, Petit T, Wechsler J, Gabison G, Pouget F, Revuz J. Faye O, et al. Ann Dermatol Venereol. 2007 Jun-Jul;134(6-7):567-9. doi: 10.1016/s0151-9638(07)89271-4. Ann Dermatol Venereol. 2007. PMID: 17657186 French.

9

Absence of efficacy of oral isotretinoin in hidradenitis suppurativa: a retrospective study based on patients' outcome assessment.

Soria A, Canoui-Poitrine F, Wolkenstein P, Poli F, Gabison G, Pouget F, Viallette C, Revuz J. Soria A, et al. Dermatology. 2009;218(2):134-5. doi: 10.1159/000182261. Epub 2008 Dec 5. Dermatology. 2009. PMID: 19060466

10

Incidence and risk factors for thalidomide neuropathy: a prospective study of 135 dermatologic patients.

Bastuji-Garin S, Ochonisky S, Bouche P, Gherardi RK, Duguet C, Djerradine Z, Poli F, Revuz J; Thalidomide Neuropathy Study Group. Bastuji-Garin S, et al. J Invest Dermatol. 2002 Nov;119(5):1020-6. doi: 10.1046/j.1523-1747.2002.19502.x. J Invest Dermatol. 2002. PMID: 12445187 Free article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

512 results

Search Page